Skip to main content
. 2013 Oct 30;23(6):1551–1562. doi: 10.1093/hmg/ddt542

Figure 1.

Figure 1.

Compound treatments reduce nuclear foci. (A–E) Images of KBTeloMyoD fibroblast cells (DM1) and KagoTelo fibroblast cells (DM2) following RNA FISH using Cy3-(CAG)10 probe (green) for the localization of the mutant transcript and Hoechst (blue) to indicate the cell nucleus. Treatment with (A) DMSO, (B) hypericin (4.4 μm), (C) Ro 31-8220 (4.4 μm), (D) gemcitabine (4.4 μm) and (E) chromomycin A3 (4.4 μm).